The Effect of a Mobile Application on Enhancing Pulmonary Rehabilitation After Lung Cancer Surgery
Launched by NATIONAL CHENG KUNG UNIVERSITY · Sep 17, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a mobile app can help patients recover their lung function after having surgery for lung cancer. The main goal is to see if using this app makes a difference in how well patients do in their rehabilitation compared to those who only receive standard care. Participants will be divided into two groups: one group will use the mobile app for exercises and support, while the other group will get traditional health education and an exercise guide. The study will last about 7 weeks, with assessments happening at different points to track progress.
To join the trial, participants must be over 20 years old, have a primary diagnosis of lung cancer, and be scheduled for lung surgery. They should be able to understand the study and give their consent. However, those with certain health issues, previous lung surgeries, or other significant medical conditions may not be eligible. Overall, this trial aims to find out if a mobile app can make recovery after lung surgery easier and more effective for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age over 20 years
- • primary diagnosis of lung cancer at any stage and type
- • referral to lung cancer resection by thoracotomy or videothoracoscopy
- • ability to understand and consent to the trial procedures
- • conscious and cognition intact
- Exclusion Criteria:
- • included adjuvant treatments (chemotherapy or radiotherapy)
- • previous history of thoracic surgery
- • neurological and/or musculoskeletal comorbidities
- • visual or hearing impairment
- • acute respiratory illness
About National Cheng Kung University
National Cheng Kung University (NCKU) is a prestigious research institution located in Tainan, Taiwan, renowned for its commitment to advancing medical science and innovation. With a strong emphasis on interdisciplinary collaboration, NCKU conducts cutting-edge clinical trials aimed at improving healthcare outcomes and addressing critical health challenges. The university leverages its extensive academic resources and state-of-the-art facilities to foster high-quality research and development, ensuring that its clinical trials adhere to rigorous ethical standards and regulatory compliance. NCKU's dedication to education, research, and community service positions it as a leading sponsor in the field of clinical research, contributing significantly to the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported